Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Retained Earnings (2016 - 2025)

Historic Retained Earnings for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to -$415.0 million.

  • AtriCure's Retained Earnings fell 745.03% to -$415.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$415.0 million, marking a year-over-year decrease of 745.03%. This contributed to the annual value of -$401.8 million for FY2024, which is 1251.84% down from last year.
  • As of Q3 2025, AtriCure's Retained Earnings stood at -$415.0 million, which was down 745.03% from -$414.7 million recorded in Q2 2025.
  • In the past 5 years, AtriCure's Retained Earnings ranged from a high of -$266.4 million in Q3 2021 and a low of -$415.0 million during Q3 2025
  • Moreover, its 5-year median value for Retained Earnings was -$347.3 million (2021), whereas its average is -$350.6 million.
  • The largest annual percentage gain for AtriCure's Retained Earnings in the last 5 years was 1519.56% (2021), contrasted with its biggest fall of 37856666.67% (2021).
  • Quarter analysis of 5 years shows AtriCure's Retained Earnings stood at -$280.2 million in 2021, then dropped by 16.59% to -$326.6 million in 2022, then fell by 9.32% to -$357.1 million in 2023, then fell by 12.52% to -$401.8 million in 2024, then fell by 3.29% to -$415.0 million in 2025.
  • Its Retained Earnings stands at -$415.0 million for Q3 2025, versus -$414.7 million for Q2 2025 and -$408.5 million for Q1 2025.